Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 6, 2010, Pages 643-653

  De Luna, Noemí ^a,b   Gallardo, Eduard ^a,b   Sonnet, Corinne ^c   Chazaud, Bénédicte ^c   Dominguez Perles, Raúl ^a,b   Suarez Calvet, Xavier ^a,b   Gherardi, Romain K ^c   Illa, Isabel ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Chemotaxis; Dysferlin; Inflammation; Macrophages; Myopathy; Myotubes; Thrombospondin 1

Indexed keywords

DYSFERLIN; MESSENGER RNA; THROMBOSPONDIN 1;

ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; MUSCLE BIOPSY; MYOBLAST; MYOPATHY; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MEMBRANE PROTEINS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOSPONDIN 1;

EID: 77953126839     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181e0d01c     Document Type: Article

References (77)

1. Bushby KM. Making sense of the limb-girdle muscular dystrophies. Brain 1999;122:1403-20
2. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001;49:130-34
3. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31-36
4. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998;20:37-42
5. Bushby KM. Dysferlin and muscular dystrophy. Acta Neurol Belg 2000; 100:142-45
6. Ho M, Gallardo E, McKenna-Yasek D, et al. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann Neurol 2002;51:129-33
7. De Luna N, Gallardo E, Illa I. In vivo and in vitro dysferlin expression in human muscle satellite cells. J Neuropathol Exp Neurol 2004;63: 1104-13
8. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003;423:168-72
9. Lennon NJ, Kho A, Bacskai BJ, et al. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 2003; 278:50466-73
10. de Luna N, Gallardo E, Soriano M, et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation Bin vitro. J Biol Chem 2006;281:17092-98
11. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology 2001;56:1472-81
12. Kesari A, Fukuda M, Knoblach S, et al. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. Am J Pathol 2008;173:1476-87
13. Glover L, Brown RH Jr. Dysferlin in membrane trafficking and patch repair. Traffic 2007;8:785-94
14. Huang Y, Laval SH, van Remoortere A, et al. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration. FASEB J 2007;21: 732-42
15. McNeil P. Membrane repair redux: Redox of MG53. Nat Cell Biol 2009; 11:7-9
16. Cai C, Weisleder N, Ko JK, et al. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3 and dysferlin. J Biol Chem 2009;284:15894-902
17. De la Torre C, Illa I, Faulkner G, et al. Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients. Proteomics 2009;3:486-97
18. Anderson LV, Davison K, Moss JA, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999;8:855-61
19. McNally EM, Ly CT, Rosenmann H, et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet 2000;91:305-12
20. Gallardo E, Rojas-Garcia R, de Luna N, et al. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology 2001;57:2136-38
21. Fanin M, Angelini C. Muscle pathology in dysferlin deficiency. Neuro-pathol Appl Neurobiol 2002;28:461-70
22. Rosenberg NL, Ringel SP, Kotzin BL. Experimental autoimmune myo-sitis in SJL/J mice. Clin Exp Immunol 1987;68:117-29
23. Bittner RE, Anderson LV, Burkhardt E, et al. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999;23:141-42
24. Kostek CA, Dominov JA, Miller JB. Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice. Am J Pathol 2002;160:833-39
25. Ho M, Post CM, Donahue LR, et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 2004;13:1999-2010
26. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208
27. Arahata K, Ishihara T, Fukunaga H, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): Immunocytochemical and genetic analyses. Muscle Nerve 1995;2:S56-66
28. Lescaudron L, Peltekian E, Fontaine-Perus J, et al. Blood borne macro-phages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord 1999;9:72-80
29. Bondesen BA, Mills ST, Kegley KM, et al. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004;287:C475-83
30. Summan M, Warren GL, Mercer RR, et al. Macrophages and skeletal muscle regeneration: A clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol 2006;290:R1488-95
31. Tidball JG, Wehling-Henricks M. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol 2007;578:327-36
32. Bryer SC, Fantuzzi G, Van Rooijen N, et al. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol 2008;180:1179-88
33. Malerba A, Vitiello L, Segat D, et al. Selection of multipotent cells and enhanced muscle reconstruction by myogenic macrophage-secreted factors. Exp Cell Res 2009;315:915-27
34. McLennan IS. Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions. J Anat 1996;188:17-28
35. Pimorady-Esfahani A, Grounds MD, McMenamin PG. Macrophages and dendritic cells in normal and regenerating murine skeletal muscle. Muscle Nerve 1997;20:158-66
36. Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007;204:1057-69
37. Sonnet C, Lafuste P, Arnold L, et al. Human macrophages rescue myo-blasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci 2006;119:2497-507
38. Robertson TA, Maley MA, Grounds MD, et al. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 1993;207:321-31
39. Cantini M, Massimino ML, Rapizzi E, et al. Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun 1995;216:49-53
40. Merly F, Lescaudron L, Rouaud T, et al. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 1999;22:724-32
41. Chazaud B, Sonnet C, Lafuste P, et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 2003;163:1133-43
42. Lluis F, Roma J, Suelves M, et al. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 2001;97:1703-11
43. De Luna N, Freixas A, Gallano P, et al. Dysferlin expression in mono-cytes: A source of mRNA for mutation analysis. Neuromuscul Disord 2007;17:69-76
44. DeFreitas MF, Yoshida CK, Frazier WA, et al. Identification of integrin alpha 3 beta 1 as a neuronal thrombospondin receptor mediating neurite outgrowth. Neuron 1995;15:333-43
45. Lawler J. The structural and functional properties of thrombospondin. Blood 1986;67:1197-209
46. Mansfield PJ, Suchard SJ. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 1994;153: 4219-29
47. Mosher DF, Doyle MJ, Jaffe EA. Synthesis and secretion of thrombo-spondin by cultured human endothelial cells. J Cell Biol 1982;93:343-48
48. Jaffe EA, Ruggiero JT, Leung LK, et al. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 1983;80:998-1002
49. Raugi GJ, Mumby SM, Abbott-Brown D, et al. Thrombospondin: Synthesis and secretion by cells in culture. J Cell Biol 1982;95:351-54
50. Asch AS, Leung LL, Shapiro J, et al. Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci USA 1986;83:2904-8
51. Moodley Y, Rigby P, Bundell C, et al. Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am J Pathol 2003;162:771-79
52. Chatila K, Ren G, Xia Y, et al. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem 2007;5:21-27
53. Li Z, Wang C, Prendergast GC, et al. Cyclin D1 functions in cell migration. Cell Cycle 2006;5:2440-42
54. Kazerounian S, Yee KO, Lawler J. Thrombospondins in cancer. Cell Mol Life Sci 2008;65:700-12
55. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev 2000;11:59-69
56. Yamauchi Y, Kuroki M, Imakiire T, et al. Opposite effects of thrombo-spondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells. Matrix Biol 2002;21:441-48
57. O'Shea KS, Dixit VM. Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 1988;107:2737-48
58. Adams JC, Lawler J. Cell typeYspecific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell 1994;5: 423-37
59. Nagaraju K, Rawat R, Veszelovszky E, et al. Dysferlin deficiency enhances monocyte phagocytosis: A model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am J Pathol 2008;172:774-85
60. Chen YW, Zhao P, Borup R, et al. Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiol-ogy. J Cell Biol 2000;151:1321-36.
61. Bakay M, Zhao P, Chen J, et al. A web-accessible complete tran-scriptome of normal human and DMD muscle. Neuromuscul Disord 2002;12(suppl 1):S125-41
62. Haslett JN, Sanoudou D, Kho AT, et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 2002;99:15000-5
63. Tezak Z, Hoffman EP, Lutz JL, et al. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: A novel model of pathogenesis. J Immunol 2002;168:4154-63
64. Haslett JN, Sanoudou D, Kho AT, et al. Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics 2003;4: 163-71
65. Salajegheh M, Raju R, Schmidt J, et al. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol 2007;187:166-74
66. Martin-Manso G, Galli S, Ridnour LA, et al. Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cyto-toxicity of differentiated U937 cells. Cancer Res 2008;68:7090-99
67. Schwartz BS. Monocyte synthesis of thrombospondin. The role of platelets. J Biol Chem 1989;264:7512-17
68. Watkins SC, Lynch GW, Kane LP, et al. Thrombospondin expression in traumatized skeletal muscle. Correlation of appearance with post-trauma regeneration. Cell Tissue Res 1990;261:73-84
69. Tseng BS, Zhao P, Pattison JS, et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol 2002;93: 537-45
70. Porter JD, Khanna S, Kaminski HJ, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002;11:263-72
71. Turk R, t'Hoen PA, Sterrenburg E, et al. Gene expression variation between mouse inbred strains. BMC Genomics 2004;5:57
72. Nakayama Y, Nara N, Kawakita Y, et al. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients. Am J Pathol 2004;164:1773-82
73. Baban D, Davies KE. Microarray analysis of mdx mice expressing high levels of utrophin: Therapeutic implications for dystrophin deficiency. Neuromuscul Disord 2008;18:239-47
74. Griffin JL, Des Rosiers C. Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: Lessons from downstream of the transcriptome. Genome Med 2009;1:32
75. Porter JD, Merriam AP, Leahy P, et al. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 2004;13:257-69
76. Mokhtarian A, Lefaucheur JP, Even PC, et al. Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. J Appl Physiol 1999;86:924-31
77. Agah A, Kyriakides TR, Lawler J, et al. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 2002;161:831-39